Structural model for deoxycytidine deamination mechanisms of the HIV-1 inactivation enzyme APOBEC3G
about
Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activitiesMultiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them allSuppression of APOBEC3-mediated restriction of HIV-1 by VifInteraction of APOBEC3A with DNA assessed by atomic force microscopyDifferent mutagenic potential of HIV-1 restriction factors APOBEC3G and APOBEC3F is determined by distinct single-stranded DNA scanning mechanismsAnalysis of a single-stranded DNA-scanning process in which activation-induced deoxycytidine deaminase (AID) deaminates C to U haphazardly and inefficiently to ensure mutational diversityNanoscale structure and dynamics of ABOBEC3G complexes with single-stranded DNA.AID and Apobec3G haphazard deamination and mutational diversityAtomic force microscopy studies of APOBEC3G oligomerization and dynamics.Cytidine deaminase efficiency of the lentiviral viral restriction factor APOBEC3C correlates with dimerization.Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity.Rationalisation of the differences between APOBEC3G structures from crystallography and NMR studies by molecular dynamics simulationsGANP interacts with APOBEC3G and facilitates its encapsidation into the virions to reduce HIV-1 infectivityStructural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulationAPOBEC3G inhibits HIV-1 RNA elongation by inactivating the viral trans-activation response element.Random mutagenesis MAPPIT analysis identifies binding sites for Vif and Gag in both cytidine deaminase domains of Apobec3G.Atomic force microscopy studies provide direct evidence for dimerization of the HIV restriction factor APOBEC3GIntensity of deoxycytidine deamination of HIV-1 proviral DNA by the retroviral restriction factor APOBEC3G is mediated by the noncatalytic domain.Retroviral restriction factor APOBEC3G delays the initiation of DNA synthesis by HIV-1 reverse transcriptase.APOBEC3G: a double agent in defenseSequence and structural determinants of human APOBEC3H deaminase and anti-HIV-1 activities.Crystal structure of DNA cytidine deaminase ABOBEC3G catalytic deamination domain suggests a binding mode of full-length enzyme to single-stranded DNA.Deaminase activity on single-stranded DNA (ssDNA) occurs in vitro when APOBEC3G cytidine deaminase forms homotetramers and higher-order complexesDirect evidence that RNA inhibits APOBEC3G ssDNA cytidine deaminase activity.Catalytic analysis of APOBEC3G involving real-time NMR spectroscopy reveals nucleic acid determinants for deamination.Characterization of the Catalytic Domain of Human APOBEC3B and the Critical Structural Role for a Conserved Methionine.APOBEC2 is a monomer in solution: implications for APOBEC3G modelsSingle-stranded DNA scanning and deamination by APOBEC3G cytidine deaminase at single molecule resolution.Antiviral Mechanism and Biochemical Basis of the Human APOBEC3 Family.APOBEC3G Interacts with ssDNA by Two Modes: AFM Studies.Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A.Natural Polymorphisms and Oligomerization of Human APOBEC3H Contribute to Single-stranded DNA Scanning Ability.HIV-1 viral infectivity factor (Vif) alters processive single-stranded DNA scanning of the retroviral restriction factor APOBEC3GA computational analysis of the structural determinants of APOBEC3's catalytic activity and vulnerability to HIV-1 Vif.Impact of H216 on the DNA binding and catalytic activities of the HIV restriction factor APOBEC3GThe ssDNA Mutator APOBEC3A Is Regulated by Cooperative DimerizationNuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity.Binding of RNA by APOBEC3G controls deamination-independent restriction of retrovirusesCrystal structures of APOBEC3G N-domain alone and its complex with DNA.The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis.
P2860
Q24310511-0F49FE2B-9B4E-495B-B819-0728FE7685EEQ26823568-D43A408D-0829-4596-BE45-99706DFDF440Q27025150-8983D1D1-8148-4E2C-8FF1-6E51E3C4DA3EQ28539478-B94DDCEE-A3EC-4638-AF03-ADE03F4ECE40Q28541264-5A8F2DEC-2029-4E24-9AF4-BADBB89B7ACAQ30502490-D9A51B3F-7139-4D9E-A591-503F30A95BE8Q30525163-5C62E967-24B6-4082-9732-37C6003619F5Q30537745-42D6BBA2-1674-4E42-95E2-794025C5692EQ30558175-0D987ACE-D515-43BD-B37A-0F9B8DD946CEQ33558327-C73A9580-2FE1-4B21-943F-F4FC58AAF6FBQ33630551-1462B8F2-A8B0-45BB-BA4E-7C07E821CC5AQ33634092-FEF6F6CB-1DB6-44C3-8F5C-05CB960B0886Q33862780-A7F609A4-D362-42DF-83FA-30A2FF7AC1EBQ33878087-CF497099-2166-4F27-BD6E-977B01CE308DQ34052968-04114CE2-B3BC-40F6-8A0D-234B619C1AB4Q34412223-4714F4F3-6F1F-439A-A7E1-1BB9C139D42FQ34536866-3D0DB1D0-A713-4603-8BAA-B2E13FD5984EQ34719668-D9056353-C713-4D86-B596-29C5201D119EQ34745411-799E7B7E-7580-4F98-9FB7-C53F6ECFC032Q34917194-7ADE3C75-6A47-473E-873A-3178B9154D1AQ35068754-890724E9-125C-4545-A637-05030A62520EQ35080239-69D4FEB7-98A7-42A7-81F5-9D818C31AF24Q35182930-EBD9113A-A1E4-448D-82E6-7A86954872A6Q35209374-5B3FFE4A-4B7E-48EA-A3FB-BF8E71AC0DC1Q35601910-A1F526DE-4D1F-422F-9D7B-8541D6FBFF92Q35747955-AA13C7D7-7909-4138-8709-55B5DBB4E8BBQ35862616-29DD78C5-0C44-4004-8681-05176A301445Q35939875-45D4524A-67B5-4DF3-A190-368AF4F3BF70Q36081987-EA281149-F737-45A3-9C0F-A2E85283B31CQ36209528-AA234064-C119-4192-BCDE-744927860DC2Q36216511-E4CEDE61-C5D7-459D-A86C-CE06EB7C01B6Q36283884-1904575F-77B8-428B-9457-FB97197DB0D6Q36647213-724373F7-758A-4C94-8C33-FFFE71461E92Q36871140-60872C11-3863-454A-8C84-5935E5552117Q36911764-9A0200DE-510E-4A11-8223-F3ADD63CB545Q36921174-A93034DE-A7A5-4062-9B07-C8AA37DA5912Q37091342-68E2E34F-E7E9-4D4C-804A-642349AD0EA6Q37122122-346B3DE2-5DD1-4665-A66C-8C0D4D2F1E87Q37153949-FC137704-5339-4DEC-A2C3-AE601AA515F6Q37281847-30398BC9-C434-456C-A2DD-1589B0B82A02
P2860
Structural model for deoxycytidine deamination mechanisms of the HIV-1 inactivation enzyme APOBEC3G
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Structural model for deoxycyti ...... 1 inactivation enzyme APOBEC3G
@ast
Structural model for deoxycyti ...... 1 inactivation enzyme APOBEC3G
@en
Structural model for deoxycyti ...... 1 inactivation enzyme APOBEC3G
@nl
type
label
Structural model for deoxycyti ...... 1 inactivation enzyme APOBEC3G
@ast
Structural model for deoxycyti ...... 1 inactivation enzyme APOBEC3G
@en
Structural model for deoxycyti ...... 1 inactivation enzyme APOBEC3G
@nl
prefLabel
Structural model for deoxycyti ...... 1 inactivation enzyme APOBEC3G
@ast
Structural model for deoxycyti ...... 1 inactivation enzyme APOBEC3G
@en
Structural model for deoxycyti ...... 1 inactivation enzyme APOBEC3G
@nl
P2093
P2860
P3181
P356
P1476
Structural model for deoxycyti ...... 1 inactivation enzyme APOBEC3G
@en
P2093
Courtney Prochnow
Dorothy A Erie
Linda Chelico
Myron F Goodman
Xiaojiang S Chen
P2860
P304
P3181
P356
10.1074/JBC.M110.107987
P407
P577
2010-05-21T00:00:00Z